Related Experiment Video
Updated: Jan 29, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
[Histoplasmosis in AIDS patients without tegumentary manifestations]
Fernando A Messina1, Marcelo Corti2, Ricardo Negroni1
1Unidad de Micología, Hospital de Enfermedades Infecciosas, Buenos Aires, Argentina.
Background:
Histoplasmosis is a mycosis with a high prevalence in HIV/AIDS patients. Clinical presentation includes a wide spectrum of manifestations and diagnosis usually takes up to several weeks in patients who do not present cutaneous lesions.
Aim:
To determine the clinical and microbiological characteristics as well as some biochemical parameters in patients with AIDS-associated histoplasmosis without tegumentary lesions, in order to develop a guideline which enables an early empiric treatment in cases of difficult diagnosis.
Methods:
Medical records of 86 patients with histoplasmosis were reviewed; 31 patients with diagnosis of AIDS-associated histoplasmosis without cutaneous lesions were analyzed.
Results:
Fever was the most frequent symptom (96.7%), lung involvement was observed in 22 patients (70.9%), the most commonly radiological pattern was miliary pattern [(12/22), 54.5%]. Nineteen patients presented with splenomegaly. Blood culture sensitivity was 93.3% (28/30) and serology was positive only in 23.5% of the cases. Eight patients died (25.8%). Patients in which CD4+ T cell lymphocytes count was < 50 cells/μl, albumin levels < 2.5 g/dl and who presented with pancytopenia had an unfavorable outcome.
Conclusions:
In HIV seropositive patients with fever associated to splenomegaly and bilateral miliar pattern in chest radiography, the empiric treatment with amphotericin B must be considered if signs and symptoms of unfavorable outcome are present and due to the time that it takes to arrive at an accurate diagnosis. In order to confirm the diagnosis, all microbiological samples should be collected prior to initiating therapy.
Insights
Early empiric treatment for AIDS-associated histoplasmosis is crucial for patients with fever, splenomegaly, and miliary lung patterns. Prompt diagnosis and treatment, especially with amphotericin B, can improve outcomes in these high-risk individuals.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Host Research
Background:
- Histoplasmosis is a significant fungal infection in Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) patients.
- Diagnosis can be delayed for weeks, especially without skin lesions.
- This study focuses on optimizing diagnosis and treatment for this specific patient group.
Purpose of the Study:
- To define clinical, microbiological, and biochemical features of AIDS-associated histoplasmosis without skin lesions.
- To establish guidelines for early empiric treatment in difficult diagnostic cases.
- To reduce mortality associated with delayed diagnosis.
Main Methods:
- Retrospective review of medical records for 86 histoplasmosis patients.
- Detailed analysis of 31 patients with AIDS-associated histoplasmosis and no cutaneous lesions.
- Evaluation of clinical symptoms, imaging, blood cultures, and serology.
Main Results:
- Fever (96.7%) and lung involvement (70.9%) were most common; miliary pattern seen in 54.5% of lung cases.
- Splenomegaly occurred in 19 patients.
- High blood culture sensitivity (93.3%) contrasted with low serology positivity (23.5%).
- Factors predicting unfavorable outcomes included CD4+ T cell count < 50 cells/μl, low albumin (< 2.5 g/dl), and pancytopenia.
- Mortality rate was 25.8%.
Conclusions:
- Empiric amphotericin B treatment should be considered for HIV-seropositive patients with fever, splenomegaly, and bilateral miliary lung patterns, especially if unfavorable outcome indicators are present.
- Collecting microbiological samples before treatment initiation is vital for accurate diagnosis.
- Early intervention is critical due to diagnostic delays and high mortality.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

